Peterson, W L <br/><br/>
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jun 1996 
 - 251-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.0953-0673.1996.00251.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--adverse effects<br/>Anti-Ulcer Agents--adverse effects<br/>Bismuth--adverse effects<br/>Clarithromycin--adverse effects<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Duodenal Ulcer--drug therapy<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori<br/>Histamine H2 Antagonists--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Compliance<br/>Ranitidine--adverse effects<br/>Recurrence